Events

Beijing -- Chinese President Xi Jinping announced on September 24, 2026 that China will invite 100,000 young Americans for exchange and study programs over the next five years, a pledge made during a White House welcome ceremony marking his state visit to the United States.

Xi unveils five-year youth exchange initiative during Washington visit

The commitment followed a wave of grassroots engagement, including nearly 100 students from 10 US universities who participated in youth exchanges in China and later wrote to Xi describing their experiences. Harvard faculty member Marlon Forrester and Columbia University student Joey Zhang, among the letter writers, told CGTN the initiative represents a foundation for sustained bilateral exchange.

Hong Kong – September 25, 2026 -- The Independent Commission Against Corruption (ICAC) of Hong Kong and the United Nations Office on Drugs and Crime (UNODC) trained 35 law enforcement officials from 19 jurisdictions in a 10-day programme running September 7 to 16, targeting the investigation of illicit enrichment by public officials.

Programme draws senior officials from 19 countries and regions

Participants came from Indonesia, Kuwait, Madagascar, Malta, Mauritius, Mongolia, Montenegro, Nigeria, Oman, Republic of Korea, Saudi Arabia, Singapore, Spain, Thailand, Tonga and Ukraine, alongside officials from the Guangdong Provincial Commission of Supervision, the UNODC Regional Corruption and Financial Crime Hub for South-East Asia and the Pacific, the Commission Against Corruption of Macao SAR, the Hong Kong Police Force, Customs and Excise Department, the Securities and Futures Commission and the Hong Kong Jockey Club.

Los Angeles – September 24, 2026 -- Young consumers trust artificial intelligence for everyday use but not for advice, according to a new industry report that has reshaped how retail and consumer brands are approaching Gen Z engagement.

Pacsun's 2026 Youth Report, developed with GlobalData, found that influencers never exceed an 11% trust share in any category tested among young consumers. Artificial intelligence shows an even starker gap between adoption and credibility: 85% of young people use AI, yet only 2% trust it for fashion advice and 5% for financial advice. The research instead points to family and friends as the primary trusted sources for this demographic.

Tokyo – September 24, 2026 -- TIER IV, the developer behind the open-source Autoware autonomous driving platform, will co-host a hands-on AI and autonomous driving education event for junior and senior high school students on September 26 at the National Museum of Emerging Science and Innovation (Miraikan) in Tokyo.

Three corporate partners jointly built the training tools deployed at the event

TIER IV is running the session in collaboration with Tamiya, Macnica and zero to one, a Kawaijuku Group company. Students will train an AI robot jointly developed by Tamiya and Macnica, testing how the system recognizes surroundings and makes decisions from sensor input.

Boston and Shenzhen – September 24, 2026 -- XtalPi Holdings Limited (HKEX: 2228) has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for KQTD-126, a potential first-in-class gut-restricted pan-tropomyosin receptor kinase (pan-TRK) inhibitor targeting chronic intestinal pain in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).

KQTD-126 marks XtalPi's first proprietary pipeline candidate to reach IND stage

The submission represents the inaugural IND filing from XtalPi's internally developed pipeline, which the company disclosed in its recent interim results. It confirms the company's transition from a discovery-services provider to a clinical-stage drug developer built on AI and robotics.

Sydney – September 24, 2026 -- Nuix (ASX:NXL) has been named a Disruptor in the Risk Infrastructure category of the Chartis RiskTech100® 2027, one of only 17 firms to receive the designation.

Chartis screened over 900 companies before naming 17 Disruptors

Chartis Research analysts reviewed more than 900 risk technology companies and engaged with over 200 shortlisted vendors for the RiskTech100 2027 program. The rankings and category winners were announced on September 24 at RiskLive North America in New York, alongside publication of the full RiskTech100 2027 report.

Rockville, Md. – September 24, 2026 -- REGENXBIO Inc. (Nasdaq: RGNX) reported that 60% of Dose Level 3 participants with three-year follow-up data in its Phase II ALTITUDE study achieved a greater-than-2-step improvement on the Diabetic Retinopathy Severity Scale (DRSS) after a single in-office treatment with investigational gene therapy sura-vec, with no vision-threatening events recorded among responders.

Three-year data confirm durable DRSS improvement without repeat injections

In long-term follow-up as of August 17, 2026, six of ten Dose Level 3 participants with non-proliferative diabetic retinopathy (NPDR) who reached the three-year visit sustained a greater-than-2-step DRSS improvement without additional diabetic retinopathy treatment. The suprachoroidal delivery used Dose Level 3 (1.0x10^12 GC/eye) combined with short-course prophylactic topical steroids.

Southlake, Texas – September 24, 2026 -- Sabre GLBL Inc., the wholly-owned subsidiary of Sabre Corporation (Nasdaq: SABR), has capped its cash tender offer at a $250 million aggregate purchase price, triggering a proration of its 10.750% Senior Secured Notes due 2029 at approximately 84.0%.

Tender offers expired September 24, 2026 with the $250 million ceiling exceeded

The tender offers closed at 5:00 p.m. New York City time on September 24, 2026, according to information supplied to D.F. King & Co., Inc., the tender and information agent. Because the aggregate purchase price of validly tendered 10.750% Notes due 2029 alone exceeded the $250 million cap, no 10.750% Senior Secured Notes due 2030 or 11.125% Senior Secured Notes due 2030 will be accepted for purchase.

Singapore – September 24, 2026 -- MetaOptics Ltd, listed on the Catalist board of the Singapore Exchange under ticker 9MT, has established a sponsored Level 1 American Depositary Receipt programme, with its American Depositary Shares set to trade on OTCQX in the United States.

J.P. Morgan named depositary bank for new ADR structure

The semiconductor optics firm has appointed J.P. Morgan to administer the ADR programme. The Company confirmed the move does not involve new share issuance or capital raising, and its ordinary shares will continue trading on Catalist without material impact to existing shareholders.

Raleigh, N.C. – September 24, 2026 -- Cardinal Infrastructure Group Inc. (Nasdaq: CDNL) has expanded its total credit facility commitments to $550 million after its subsidiary, Cardinal Civil Contracting, LLC, signed a second amendment to its senior secured credit agreement.

New $250 million delayed draw term loan targets acquisitions

The amendment adds a delayed draw term loan facility of up to $250 million, which the company can access in as many as five separate advances over 18 months through March 2028. Cardinal intends to use the proceeds to finance permitted acquisitions and related fees and expenses. The facility remained undrawn at the completion of syndication.

Pune – September 24, 2026 -- The global autoimmune treatment market reached USD 176.6 billion in 2025 and is forecast to expand at a 6.9% CAGR through 2034, hitting USD 321.95 billion, according to a new analysis from Maximize Market Research.

North America dominates the market on strong pharmaceutical R&D infrastructure

North America held the largest share of the market in 2025, driven by high disease prevalence, advanced healthcare infrastructure, established specialist care and elevated healthcare spending. The United States anchors regional growth, backed by leading pharmaceutical and biotechnology firms, advanced diagnostic capacity, and rising adoption of biologics, immunosuppressants, monoclonal antibodies and targeted therapies. Canada and Mexico are contributing through improving healthcare access and disease awareness.

Pune, India – September 24, 2026 -- The global nanomedicine market reached USD 207.91 billion in 2025 and is projected to hit USD 581.2 billion by 2034, expanding at a 12.1% compound annual growth rate, according to a new report from Maximize Market Research.

North America commands the largest share on pharmaceutical R&D strength

North America held the largest share of the market in 2025, driven by advanced healthcare infrastructure, deep pharmaceutical and biotechnology research pipelines, and high healthcare expenditure. The United States anchors regional growth through its established research ecosystem and rising adoption of nanotechnology-based drug delivery, diagnostics and precision medicine platforms. Canada and Mexico are contributing through expanding healthcare capabilities and research initiatives.

San Francisco – September 24, 2026 -- The U.S. Bankruptcy Court for the District of New Jersey approved HouseCanary's first-day motions, granting the property intelligence provider access to debtor-in-possession financing and clearing the way for uninterrupted operations during its Chapter 11 reorganization.

Court clears customer, employee and financing relief on first-day hearing

The approved motions cover continuation of customer programs, employee obligations and ordinary-course business operations, alongside debtor-in-possession financing to bolster liquidity. A further hearing is scheduled for October to consider additional debtor-in-possession financing for the company.

Bogotá – September 24, 2026 -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) named Joaquín Gutiérrez Caballero as permanent Chief Executive Officer, effective September 28, 2026, following a unanimous board vote.

Board replaces interim leadership with unanimous vote

The appointment ends the interim tenure of Camilo Barco, who steps down as CEO effective September 27, 2026. All members of Ecopetrol's Board of Directors participated in the vote, which followed a selection process run by the Board's Compensation, Nomination and Culture Committee under the company's Succession Policy.

Incoming CEO brings 30 years of cross-sector experience

Gutiérrez Caballero holds a degree in Business Administration and postgraduate specializations in Telecommunications Project Management, Telecommunications Law, and Healthcare Services Management. He has more than 30 years of professional experience, according to the company.

Easton, PA – September 24, 2026 -- A structured construction management workflow is reducing cost overruns and schedule delays on market-rate residential projects, according to a new HelloNation article featuring insights from Construction Management Expert Jovana Villanueva of Easton, PA.

Pre-construction planning cuts change orders before ground is broken

The article details how early cost modeling, material availability checks, and constructability reviews of architectural drawings identify design conflicts before construction starts. This upfront analysis is presented as the primary lever developers have to reduce change orders and keep projects aligned with financial targets from day one.

St. Petersburg – September 24, 2026 -- ARK Investment Management LLC has launched the ARK Active Autocallable Income ETF (ARKY), targeting a 17.5% coupon by applying a volatility-harvesting strategy to its disruptive-innovation equity universe. The fund began trading on the Cboe BZX Exchange, marking ARK's first entry into the income-strategy category.

ARKY diversifies risk across 25 to 50 single-stock autocallable positions

Each holding in the portfolio references a single stock from ARK's high-conviction innovation universe and carries a 50% to 60% coupon barrier. A breach in one underlying asset affects only that position, while the remaining portfolio can continue generating income, according to the company.

Pune, India – September 24, 2026 -- The global multiple sclerosis treatment market reached USD 26.76 billion in 2025 and is forecast to climb to USD 44.45 billion by 2034, expanding at a 5.8% CAGR, according to a new report from Maximize Market Research.

Disease-modifying therapies and biologics drive current market expansion

Rising MS prevalence, improved diagnostic capabilities, and growing adoption of immunomodulators, immunosuppressants, interferons, oral disease-modifying therapies (DMTs), and monoclonal antibodies are fueling demand across relapsing-remitting (RRMS), primary progressive (PPMS), secondary progressive (SPMS), and clinically isolated syndrome (CIS) patient segments. High-efficacy biologics and oral treatment options are increasingly displacing older therapy classes as patients and physicians prioritize convenience and disease-progression control.

Pune, India – September 24, 2026 -- The global placenta market is set to nearly triple from USD 96.1 billion in 2025 to USD 275.18 billion by 2034, expanding at a 12.4% compound annual growth rate, according to a new analysis by Maximize Market Research.

Asia-Pacific leads global demand as Japan, South Korea and China drive placenta research

Asia-Pacific held the leading market position in 2025, backed by strong placenta research and development in Japan, South Korea and China, alongside rising production of placenta-derived products for pharmaceutical and cosmetics applications. The region's large consumer base and appetite for anti-aging and skincare solutions continue to underpin its dominant position.

Austin, Texas – September 24, 2026 -- Forge AI Deployment has committed $30 million to webAI to build and deploy private, specialized AI systems for enterprise customers, the companies announced.

Forge pairs $30 million commitment with webAI's collaborative intelligence platform

The deal combines webAI's technology with Forge's enterprise deployment and services operation. Forge will work directly with customers to build AI systems around proprietary data, workflows and operations, running on infrastructure those customers control, from individual specialized AI Personas to company-wide deployments.

Washington – September 24, 2026 -- State insurance regulators leading the National Association of Insurance Commissioners (NAIC) responded to a letter from U.S. Senator Elizabeth Warren (D-Mass.) by detailing a series of capital and oversight changes made in recent years to address insurers' shifting investment strategies, ownership structures, and risk-transfer arrangements.

Regulators impose a 45% risk-based capital charge on structured security residuals